Angelman Syndrome clinical trials at UCLA

1 in progress, 0 open to eligible people

Showing trials for

  • Long-term Extension of GTX-102 in Angelman Syndrome

    Sorry, accepting new patients by invitation only

    The primary objective of the study is to evaluate the long-term safety profile of GTX-102 in participants with Angelman Syndrome (AS)

    Los Angeles 5368361, California 5332921 and other locations

Our lead scientists for Angelman Syndrome research studies include .

Last updated: